demonstrated that high expression of IL‐1R1 led to resistance to both immunotherapy and adjuvant chemotherapy in gastric cancer.[21a] These findings underscore the significance of IL‐1/IL‐1R1 signaling in treatment resistance mechanisms. The gene discussed is IL1A; the disease is gastric cancer.